Ratos AB (FRA:RAZB)
€ 2.924 0.016 (0.55%) Market Cap: 959.25 Mil Enterprise Value: 1.61 Bil PE Ratio: 12.41 PB Ratio: 0.96 GF Score: 70/100

Q2 2024 Ratos AB Earnings Call Transcript

Jul 18, 2024 / 07:00AM GMT
Release Date Price: €3.33 (+0.73%)

Key Points

Positve
  • EBITDA increased despite a 10% organic decline in net sales.
  • Strong order intake, particularly in the construction segment with a 72% increase.
  • Cash flow was robust with a cash conversion rate of 127%.
  • Technical consultancy companies and industry product solutions showed strong development.
  • Return on capital employed and return on invested capital both improved.
Negative
  • Net sales decreased by 9% overall, with a 10% organic decline.
  • Plantasjen had a very weak quarter, significantly impacting group results.
  • The construction market remains weak, affecting overall sales.
  • The CRO market, especially for biotech companies, has been weak.
  • Inventory levels, while reduced, still require further management and reduction efforts.
Josefine Uppling
Ratos AB - VP - Communication & Sustainability

Good morning and welcome to this presentation covering the second quarter and the first half of 2024. In Ratos, I am joined by our CFO, Jonas Agrup; and our CEO, Jonas Wiström here in the studio, and they will guide us through the results shortly.

(Event Instructions) And this webcast is also recorded. So you will find it afterwards at ratos.com.

Without further ado, I'll leave over to you, Jonas Wiström.

Jonas WistrÃ;m
Ratos AB - President, CEO, & Director

¶ -

Thank you so much, Josephine, and thank you all for joining us this very, very busy reporting day. We start off with a rehearsal for -- if there are any new viewers here, we have three business areas, but we have five segments and you see that is industrial services, product solutions, critical infrastructure, construction and consumer, and we will go deeper into this area.

All in all, I'm satisfied with this quarter where the demand in markets really have been varied. We had an EBITDA

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot